(Q53540861)

English

Relationship of serum TWEAK level to cytokine level, disease activity, and response to anti-TNF treatment in patients with rheumatoid arthritis.

scientific article

In more languages

default for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

15 May 2018

http://europepmc.org/abstract/MED/18465450

Relationship of serum TWEAK level to cytokine level, disease activity, and response to anti-TNF treatment in patients with rheumatoid arthritis. (English)

1 reference

Europe PubMed Central

PubMed publication ID

15 May 2018

http://europepmc.org/abstract/MED/18465450

0 references

0 references

rheumatoid arthritis

1 reference

based on heuristic

inferred from title

1 reference

ORCID Public Data File 2021

author name string

M-C Park

1

1 reference

Europe PubMed Central

PubMed publication ID

15 May 2018

http://europepmc.org/abstract/MED/18465450

S J Chung

2

1 reference

Europe PubMed Central

PubMed publication ID

15 May 2018

http://europepmc.org/abstract/MED/18465450

Y-B Park

3

1 reference

Europe PubMed Central

PubMed publication ID

15 May 2018

http://europepmc.org/abstract/MED/18465450

S-K Lee

4

1 reference

Europe PubMed Central

PubMed publication ID

15 May 2018

http://europepmc.org/abstract/MED/18465450

publication date

1 May 2008

1 reference

Europe PubMed Central

PubMed publication ID

15 May 2018

http://europepmc.org/abstract/MED/18465450

Scandinavian Journal of Rheumatology

1 reference

Europe PubMed Central

PubMed publication ID

15 May 2018

http://europepmc.org/abstract/MED/18465450

37

1 reference

Europe PubMed Central

PubMed publication ID

15 May 2018

http://europepmc.org/abstract/MED/18465450

3

1 reference

Europe PubMed Central

PubMed publication ID

15 May 2018

http://europepmc.org/abstract/MED/18465450

173-178

1 reference

Europe PubMed Central

PubMed publication ID

15 May 2018

http://europepmc.org/abstract/MED/18465450

Signaling by the TNF receptor superfamily and T cell homeostasis

1 reference

https://api.crossref.org/works/10.1080%2F03009740801898608

21 January 2018

The CD95 (APO-1/Fas) and the TRAIL (APO-2L) apoptosis systems

1 reference

https://api.crossref.org/works/10.1080%2F03009740801898608

21 January 2018

TWEAK, a new secreted ligand in the tumor necrosis factor family that weakly induces apoptosis

1 reference

https://api.crossref.org/works/10.1080%2F03009740801898608

21 January 2018

Identification of a ligand for the death-domain-containing receptor Apo3

1 reference

https://api.crossref.org/works/10.1080%2F03009740801898608

21 January 2018

Involvement of TWEAK in interferon gamma-stimulated monocyte cytotoxicity

1 reference

https://api.crossref.org/works/10.1080%2F03009740801898608

21 January 2018

TWEAK induces NF-kappaB2 p100 processing and long lasting NF-kappaB activation.

1 reference

https://api.crossref.org/works/10.1080%2F03009740801898608

21 January 2018

TWEAK induces angiogenesis and proliferation of endothelial cells

1 reference

https://api.crossref.org/works/10.1080%2F03009740801898608

21 January 2018

Pro-inflammatory effect of TWEAK/Fn14 interaction on human umbilical vein endothelial cells

1 reference

https://api.crossref.org/works/10.1080%2F03009740801898608

21 January 2018

Proinflammatory activity of TWEAK on human dermal fibroblasts and synoviocytes: blocking and enhancing effects of anti-TWEAK monoclonal antibodies

1 reference

https://api.crossref.org/works/10.1080%2F03009740801898608

21 January 2018

TWEAK/Fn14 interaction stimulates human bronchial epithelial cells to produce IL-8 and GM-CSF.

1 reference

https://api.crossref.org/works/10.1080%2F03009740801898608

21 January 2018

TWEAK can induce pro-inflammatory cytokines and matrix metalloproteinase-9 in macrophages

1 reference

https://api.crossref.org/works/10.1080%2F03009740801898608

21 January 2018

The role of TWEAK/Fn14 in the pathogenesis of inflammation and systemic autoimmunity

1 reference

https://api.crossref.org/works/10.1080%2F03009740801898608

21 January 2018

Cytokine pathways and joint inflammation in rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1080%2F03009740801898608

21 January 2018

Rheumatoid arthritis. Pathophysiology and implications for therapy

1 reference

https://api.crossref.org/works/10.1080%2F03009740801898608

21 January 2018

Role of cytokines, acute-phase proteins, and chemokines in the progression of rheumatoid arthritis.

1 reference

https://api.crossref.org/works/10.1080%2F03009740801898608

21 January 2018

Pathogenesis of rheumatoid arthritis: targeting cytokines

1 reference

https://api.crossref.org/works/10.1080%2F03009740801898608

21 January 2018

Infliximab and methotrexate in the treatment of rheumatoid arthritis. Anti-Tumor Necrosis Factor Trial in Rheumatoid Arthritis with Concomitant Therapy Study Group

1 reference

https://api.crossref.org/works/10.1080%2F03009740801898608

21 January 2018

Adalimumab, a fully human anti-tumor necrosis factor alpha monoclonal antibody, for the treatment of rheumatoid arthritis in patients taking concomitant methotrexate: the ARMADA trial

1 reference

https://api.crossref.org/works/10.1080%2F03009740801898608

21 January 2018

A trial of etanercept, a recombinant tumor necrosis factor receptor:Fc fusion protein, in patients with rheumatoid arthritis receiving methotrexate

1 reference

https://api.crossref.org/works/10.1080%2F03009740801898608

21 January 2018

The chemokine receptors CXCR3 and CCR5 mark subsets of T cells associated with certain inflammatory reactions

1 reference

https://api.crossref.org/works/10.1080%2F03009740801898608

21 January 2018

The american rheumatism association 1987 revised criteria for the classification of rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1080%2F03009740801898608

21 January 2018

Evaluation of diagnostic criteria for ankylosing spondylitis. A proposal for modification of the New York criteria

1 reference

https://api.crossref.org/works/10.1080%2F03009740801898608

21 January 2018

Modified disease activity scores that include twenty-eight-joint counts. Development and validation in a prospective longitudinal study of patients with rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1080%2F03009740801898608

21 January 2018

Studies on the interaction between TWEAK and the death receptor WSL-1/TRAMP (DR3)

1 reference

https://api.crossref.org/works/10.1080%2F03009740801898608

21 January 2018

A novel TNF receptor family member binds TWEAK and is implicated in angiogenesis

1 reference

https://api.crossref.org/works/10.1080%2F03009740801898608

21 January 2018

TWEAK mediates signal transduction and differentiation of RAW264.7 cells in the absence of Fn14/TweakR. Evidence for a second TWEAK receptor

1 reference

https://api.crossref.org/works/10.1080%2F03009740801898608

21 January 2018

An endogenous hybrid mRNA encodes TWE-PRIL, a functional cell surface TWEAK-APRIL fusion protein

1 reference

https://api.crossref.org/works/10.1080%2F03009740801898608

21 January 2018

Multiple pathways of TWEAK-induced cell death

1 reference

https://api.crossref.org/works/10.1080%2F03009740801898608

21 January 2018

TWEAK can induce cell death via endogenous TNF and TNF receptor 1.

1 reference

https://api.crossref.org/works/10.1080%2F03009740801898608

21 January 2018

CCR5 is characteristic of Th1 lymphocytes

1 reference

https://api.crossref.org/works/10.1080%2F03009740801898608

21 January 2018

Identifiers

10.1080/03009740801898608

1 reference

Europe PubMed Central

PubMed publication ID

15 May 2018

http://europepmc.org/abstract/MED/18465450

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

15 May 2018

http://europepmc.org/abstract/MED/18465450

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q53540861&oldid=1585890593"